Literature DB >> 25132743

Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Luciana Rigoli1, Rosario Alberto Caruso1.   

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are the two main forms of inflammatory bowel disease (IBD) with both overlapping and distinct clinical, pathological and biomolecular features. It has been suggested that pediatric IBD is a distinct disease entity, with probably different disease subtypes.The aim of this study is to review and summarize the evolution of the current concept of pediatric IBD. The results of this review reinforce the idea that pediatric CD and UC may be further classified in various clinicopathologic entities. For clinicians and pathologists convenience, practical algorithms for the distinction of the various subphenotypes of pediatric IBD are also provided.

Entities:  

Keywords:  Crohn’s disease; Histopathology; Molecular biology; Pediatric inflammatory bowel disease; Ulcerative disease

Mesh:

Substances:

Year:  2014        PMID: 25132743      PMCID: PMC4130834          DOI: 10.3748/wjg.v20.i30.10262

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  178 in total

Review 1.  Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future?

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Dig Dis       Date:  2010-09-30       Impact factor: 2.404

2.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

Review 3.  Indeterminate colitis: a review of the concept--what's in a name?

Authors:  Karel Geboes; Jean-Frédéric Colombel; Adrian Greenstein; Derek P Jewell; William J Sandborn; Morten H Vatn; Bryan Warren; Robert H Riddell
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

4.  Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.

Authors:  Toshihiko Okazaki; Ming-Hsi Wang; Patricia Rawsthorne; Michael Sargent; Lisa Wu Datta; Yin Yao Shugart; Charles N Bernstein; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

5.  Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia.

Authors:  M Frye; J Bargon; B Lembcke; T O Wagner; R Gropp
Journal:  Eur J Clin Invest       Date:  2000-08       Impact factor: 4.686

6.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

Review 7.  Advances and perspectives in the genetics of inflammatory bowel diseases.

Authors:  Mathias Chamaillard; Razvan Iacob; Pierre Desreumaux; Jean-Frederic Colombel
Journal:  Clin Gastroenterol Hepatol       Date:  2006-02       Impact factor: 11.382

8.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.

Authors:  Subra Kugathasan; Robert N Baldassano; Jonathan P Bradfield; Patrick M A Sleiman; Marcin Imielinski; Stephen L Guthery; Salvatore Cucchiara; Cecilia E Kim; Edward C Frackelton; Kiran Annaiah; Joseph T Glessner; Erin Santa; Tara Willson; Andrew W Eckert; Erin Bonkowski; Julie L Shaner; Ryan M Smith; F George Otieno; Nicholas Peterson; Debra J Abrams; Rosetta M Chiavacci; Robert Grundmeier; Petar Mamula; Gitit Tomer; David A Piccoli; Dimitri S Monos; Vito Annese; Lee A Denson; Struan F A Grant; Hakon Hakonarson
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

9.  ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls.

Authors:  Hai-Feng Zhang; Li-Xin Qiu; Yu Chen; Wa-Li Zhu; Chen Mao; Li-Guang Zhu; Ming-Hua Zheng; Yan Wang; Lei Lei; Jian Shi
Journal:  Hum Genet       Date:  2009-04-01       Impact factor: 4.132

10.  Common variants at five new loci associated with early-onset inflammatory bowel disease.

Authors:  Marcin Imielinski; Robert N Baldassano; Anne Griffiths; Richard K Russell; Vito Annese; Marla Dubinsky; Subra Kugathasan; Jonathan P Bradfield; Thomas D Walters; Patrick Sleiman; Cecilia E Kim; Aleixo Muise; Kai Wang; Joseph T Glessner; Shehzad Saeed; Haitao Zhang; Edward C Frackelton; Cuiping Hou; James H Flory; George Otieno; Rosetta M Chiavacci; Robert Grundmeier; Massimo Castro; Anna Latiano; Bruno Dallapiccola; Joanne Stempak; Debra J Abrams; Kent Taylor; Dermot McGovern; Gary Silber; Iwona Wrobel; Antonio Quiros; Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmuda; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephen R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; J P Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwillam; Mark Tremelling; Panos Delukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly; Melvin B Heyman; George D Ferry; Barbara Kirschner; Jessica Lee; Jonah Essers; Richard Grand; Michael Stephens; Arie Levine; David Piccoli; John Van Limbergen; Salvatore Cucchiara; Dimitri S Monos; Stephen L Guthery; Lee Denson; David C Wilson; Straun F A Grant; Mark Daly; Mark S Silverberg; Jack Satsangi; Hakon Hakonarson
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

View more
  12 in total

1.  Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn's Disease.

Authors:  Margaret Delday; Imke Mulder; Elizabeth T Logan; George Grant
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

Review 2.  Redefining the IBDs using genome-scale molecular phenotyping.

Authors:  Terrence S Furey; Praveen Sethupathy; Shehzad Z Sheikh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-05       Impact factor: 46.802

3.  Calcium/calmodulin-dependent protein kinase IV (CaMKIV) activation contributes to the pathogenesis of experimental colitis via inhibition of intestinal epithelial cell proliferation.

Authors:  Kellie E Cunningham; Elizabeth A Novak; Garret Vincent; Vei Shaun Siow; Brian D Griffith; Sarangarajan Ranganathan; Matthew R Rosengart; Jon D Piganelli; Kevin P Mollen
Journal:  FASEB J       Date:  2018-08-16       Impact factor: 5.191

4.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

Review 5.  Mitochondrial dysfunction in inflammatory bowel disease.

Authors:  Elizabeth A Novak; Kevin P Mollen
Journal:  Front Cell Dev Biol       Date:  2015-10-01

6.  Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease.

Authors:  Walid Mottawea; Cheng-Kang Chiang; Marcus Mühlbauer; Amanda E Starr; James Butcher; Turki Abujamel; Shelley A Deeke; Annette Brandel; Hu Zhou; Shadi Shokralla; Mehrdad Hajibabaei; Ruth Singleton; Eric I Benchimol; Christian Jobin; David R Mack; Daniel Figeys; Alain Stintzi
Journal:  Nat Commun       Date:  2016-11-23       Impact factor: 14.919

Review 7.  An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets.

Authors:  Shahram Nemati; Shahram Teimourian
Journal:  Middle East J Dig Dis       Date:  2017-04

Review 8.  Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

Authors:  Eirini Giannoudaki; Siobhan Gargan; Seamus Hussey; Aideen Long; Patrick T Walsh
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

9.  Specific neurophysiological mechanisms underlie cognitive inflexibility in inflammatory bowel disease.

Authors:  Vanessa A Petruo; Sebastian Zeißig; Renate Schmelz; Jochen Hampe; Christian Beste
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

10.  Loss of Nckx3 Exacerbates Experimental DSS-Induced Colitis in Mice through p53/NF-κB Pathway.

Authors:  Dinh Nam Tran; Seon Myeong Go; Seon-Mi Park; Eui-Man Jung; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.